Pre-exposure prophylaxis for prevention of HIV infection.
作者信息
Joseph Lee Wei En, Lim Sze Wern, Choy Chiaw Yee, Wong Chen Seong
机构信息
SingHealth Polyclinics - Outram, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital; National Centre for Infectious Diseases, Singapore.
出版信息
Singapore Med J. 2023 Oct;64(10):624-628. doi: 10.4103/singaporemedj.SMJ-2022-018.
Abstract
摘要
相似文献
1
Pre-exposure prophylaxis for prevention of HIV infection.暴露前预防以预防艾滋病毒感染。
Singapore Med J. 2023 Oct;64(10):624-628. doi: 10.4103/singaporemedj.SMJ-2022-018.
2
Editorial Commentary: Keeping Our Eyes on the Prize: No New HIV Infections With Increased Use of HIV Pre-exposure Prophylaxis.编辑评论：紧盯目标：随着艾滋病病毒暴露前预防措施使用的增加，实现无新增艾滋病病毒感染
Clin Infect Dis. 2015 Nov 15;61(10):1604-5. doi: 10.1093/cid/civ783. Epub 2015 Sep 1.
3
[From Evidence to Health Policy Making: Pre-Exposure Prophylaxis for HIV Prevention].[从证据到卫生政策制定：艾滋病病毒预防的暴露前预防]
Hu Li Za Zhi. 2016 Dec;63(6):18-22. doi: 10.6224/JN.63.6.18.
4
[HIV pre-exposure prophylaxis in women].
MMW Fortschr Med. 2017 Jun;159(Suppl 2):42-44. doi: 10.1007/s15006-017-9736-9.
5
Implementing pre-exposure prophylaxis for HIV prevention in women: the role of the obstetrician-gynecologist.在女性中实施暴露前预防以预防艾滋病病毒：妇产科医生的作用。
Am J Obstet Gynecol. 2022 Jun;226(6):764-772. doi: 10.1016/j.ajog.2021.12.263. Epub 2021 Dec 29.
6
HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami.迈阿密受庇护妇女的艾滋病毒风险、暴露前和暴露后预防的知晓情况及兴趣
Int J STD AIDS. 2016 Sep;27(10):873-81. doi: 10.1177/0956462415601304. Epub 2015 Sep 18.
7
Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.男男性行为者的 HIV 预防暴露前预防是否会改变风险行为？系统评价。
J Clin Nurs. 2018 Sep;27(17-18):3254-3265. doi: 10.1111/jocn.13990.
8
Polarised press reporting about HIV prevention: Social representations of pre-exposure prophylaxis in the UK press.关于 HIV 预防的极化新闻报道：英国新闻界对暴露前预防的社会认知。
Health (London). 2017 Sep;21(5):478-497. doi: 10.1177/1363459316649763. Epub 2016 May 22.
9
Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection.HIV感染筛查及暴露前预防以预防HIV感染
Am Fam Physician. 2019 Nov 15;100(10):637-638.
10
Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.抗逆转录病毒药物预防 HIV 感染：暴露前预防、暴露后预防和治疗作为预防的临床方法。
Infect Dis Clin North Am. 2019 Sep;33(3):629-646. doi: 10.1016/j.idc.2019.04.002. Epub 2019 Jun 22.
本文引用的文献
1
Guidance for the prescription of human immunodeficiency virus pre-exposure prophylaxis in Singapore.新加坡人类免疫缺陷病毒暴露前预防用药指南。
Singapore Med J. 2024 May 1;65(5):308-311. doi: 10.11622/smedj.2022043. Epub 2022 Apr 3.
2
Pre-exposure prophylaxis and primary care.暴露前预防与初级保健。
Br J Gen Pract. 2020 Jul 30;70(697):409-410. doi: 10.3399/bjgp20X712097. Print 2020 Aug.
3
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.人乳头瘤病毒疫苗接种：免疫实践咨询委员会的最新建议。
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.
4
Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service.接受都市内卫生服务机构艾滋病毒暴露前预防的患者的肾功能和肾脏疾病风险因素。
PLoS One. 2019 Jan 17;14(1):e0210106. doi: 10.1371/journal.pone.0210106. eCollection 2019.
5
Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV.HIV 暴露前预防前后性传播感染的发生率。
AIDS. 2018 Feb 20;32(4):523-530. doi: 10.1097/QAD.0000000000001718.
6
Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.简要报告：替诺福韦艾拉酚胺（TAF）与富马酸替诺福韦二吡呋酯（TDF）分别与埃替拉韦、考比司他和恩曲他滨（E/C/F）联合用于初治HIV-1感染的随机、双盲比较：第144周结果
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):211-218. doi: 10.1097/QAI.0000000000001350.
7
Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.暴露前预防：关于医疗服务提供者行为及增加初级保健中暴露前预防实施率的干预措施的叙述性综述
J Gen Intern Med. 2017 Feb;32(2):192-198. doi: 10.1007/s11606-016-3899-4. Epub 2016 Oct 19.
8
Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.基于替诺福韦的HIV暴露前预防导致血清肌酐升高：随机安慰剂对照试验的荟萃分析
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e115-8. doi: 10.1097/QAI.0000000000000906.
9
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.暴露前预防以预防HIV-1感染（PROUD）：一项实用开放标签随机试验试点阶段的有效性结果
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
10
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.恩曲他滨/替诺福韦对HIV阴性者骨矿物质密度影响的随机双盲安慰剂对照试验
Clin Infect Dis. 2015 Aug 15;61(4):572-80. doi: 10.1093/cid/civ324. Epub 2015 Apr 23.
Zotero 插件